Skip to main content
News in Brief

How cervical cancer screening saves lives

  • from Shaastra :: vol 05 issue 11 :: Nov 2026
Cervical cancer screening ensures early diagnosis and treatment.

Study flags high cervical cancer rate among younger females in low-income countries.

Global cervical cancer deaths may rise by 39.3% in 2050, says a new study. Though it is preventable, 369,000 people died from this cancer, and 887,000 new cases were recorded globally in 2023. In India, 138,000 cases were recorded.

The study (bit.ly/cervical-study) in Nature Medicine estimated cervical cancer incidence, mortality and disability-adjusted life years (DALYs) across 204 countries and territories from 1990 to 2023, and made forecasts for 2050. One of the largest cervical cancer surveys ever, it was part of the Global Burden of Disease study of the World Health Organization (WHO).

It also highlights disparities between low- and high-income countries: in 2023, the age-standardised incidence rate and age-standardised mortality rates were, respectively, over four and seven times higher in poorer countries. The low-income countries also had a high incidence of cervical cancer among younger females, with the incidence exceeding 40 per 100,000 at ages 25–29 years, and rising above 100 per 100,000 by ages 30–34 years. 

"Rather than a gradual increase with age as seen in the high-income group, mortality rates in the low-income group plateaued at peak levels from ages 40–44 years onward, indicating disproportionate mortality burden in younger women, who are also more likely to be mothers with young children," the study says.

The gains made in management and control of cervical cancer in recent decades in high-income countries have been mainly linked to high rates of HPV (human papillomavirus) vaccination. Countries with high vaccination rates have reduced cervical cancer rates.

India has one of the largest populations with cervical cancer, which is the second leading cause of death among all cancers in females.

India has one of the largest populations with cervical cancer, which is the second leading cause of death among all cancers in females. In February 2026, the government launched a nationwide HPV vaccination drive. "This is a good start," says Marie Ng, an Associate Professor at the Yong Loo Lin School of Medicine, National University of Singapore, and one of the senior authors of the study.

However, it could be decades before the gains from these vaccinations can be assessed. "There is no magic bullet; even with vaccination and screening, it will take many years to see the effect," Ng says.

The study adds that regular screening ensures early diagnosis and treatment. The low-income countries also fare poorly on regular screening. The differences in the incidence and outcomes of cervical cancer in countries are a "disturbing reality of inequity", Ng says.

LEAVE A COMMENT

Search by Keywords, Topic or Author

© 2026 IIT MADRAS - All rights reserved

Powered by ADK RAGE